Split Specimen Testing Sample Clauses
Split Specimen Testing. Any employee who questions the results of a required drug test under this policy may, within 72 hours of having been notified of a verified positive test by the MRO, request that an additional test be conducted on the split sample (Bottle B) of the original specimen that was voided. This test will be conducted at a different DHHS certified laboratory, selected by the employee. The test must be conducted on the split sample that was provided at the same time as the original sample. If Bottle B also tests positive, then the employee may be subject to disciplinary sanctions, up to and including termination. If the testing of Bottle B produces a negative result, or for any reason Bottle B is not available, the test is considered cancelled and no sanctions are imposed. However, a re-collection under direct observation may be ordered at the MRO’s sole discretion. The employee shall bear the responsibility of paying for the testing of the split specimen (Bottle B).
Split Specimen Testing. Split specimen collection procedures will be followed in obtaining specimens for DOT safety sensitive employees only according DOT drug testing regulations. An employee is entitled to request, within 72 hours of learning of a verified positive test result, that the split urine specimen be tested at a different DHHS certified laboratory than that which conducted the test of the primary specimen. If the test result of the split specimen fails to reconfirm the presence of the drug or drug metabolite, the test result shall be ruled “Canceled”. The procedures for canceled tests, as outlined in 49 CFR Part 40.187, will be followed. If the test result of the split specimen is positive, the test results shall be deemed positive. If the laboratory’s test of the primary specimen is positive, adulterated or substituted and the split specimen is unavailable for testing, a recollection under direct observation is required. Direct observation collection procedures will be in accordance with 49 CFR Part 40 as amended. Non-DOT employees with single urine sample collections shall be the sample of record for testing. Split Specimen Testing is not authorized for test results reported by the MRO as “Invalid”.